The Dutch Colorectal Cancer Group (DCCG) is a collaboration between medical disciplines that are relevant for the diagnosis and treatment of colorectal cancer (surgical oncology radiotherapy medical oncology pathology radiology gastroenterology).

  • English
  • Dutch
Current path: Home » > DCCG trials

SCRIPT

Introduction

In July 2007 the second amendment of the SCRIPT study was approved by the Central Medical Ethical Committee. In the past only patients with preoperative short term radiotherapy could be randomised. Now patients who have received preoperative long term radiotherapy in combination with 5FU based chemotherapy (chemoradiotherapy) can be randomised as well. This amendment was incorporated in the protocol version June 2007. A new quick reference card was outlined, the patient information sheet and the CRFs were adapted. Investigators of the participating centres received the above mentioned documents in October 2007.

Downloads

Datamanagement

LUMC
Datacenter Heelkunde, K6-R
P.O. Box 9600,
2300 RC LEIDEN,
The Netherlands
Tel. +31-71-5263500,
fax. +31-71-5266744
E-mail:datacenter@lumc.nl

More information

More information about this trial is available at our members only page.

Diagnosis

Back to top


Site navigation

Back to top


The Dutch Colorectal Cancer Group (DCCG) is a collaboration between medical disciplines that are relevant for the diagnosis and treatment of colorectal cancer (surgical oncology radiotherapy medical oncology pathology radiology gastroenterology).